United States
- Clinical rotation (15 wards): Reviewed patient's medication history, identified drug-drug interaction, advised optimal, and assessed feasibility of medication under national health insurance (NHI). - Speakers of 13 case conferences: systematic reviewed according to patient's PICO, streamlined information from literatures and clinical guidelines, and provided evidence-based recommendations to clinical team. - Evaluated 60 antibiotics consultations, 14 adverse drug reaction (ADR) reports, 12 cases of therapeutic drug monitoring (TDM), and 470 potential inappropriate medications (PIMs).
- Organized and designed assignments of common inappropriate medications in clinical practice. - Led group discussion on medication treatment in liver transplantation and non ST-segment elevation myocardial infarction (NSTEMI).
- Speaker of case report ''Combination Therapy of Pembrolizumab and Chemotherapy in non small-cell lung cancer.'' Summarized key points of KEYNOTE-189, clarified differences of effectiveness across PD-L1 expression and organized other combination therapy with immune checkpoint inhibitors. - Educated patient on safety issues of dual antiplatelet therapy (DAPT) and instructions of bronchodilators.
- Investigated population sizes of anesthesia from healthcare database and analyzed market potential for unlaunched product. - Identified pros and cons of unlaunched product from literature review, and formulated future marketing strategies. - Extracted essential information from the protocol of influenza vaccine and arranged standard answers for frequently asked questions (FAQs).